MASTROMARINO, MARGHERITA

MASTROMARINO, MARGHERITA  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.036 secondi).
Titolo Data di pubblicazione Autore(i) File
Aurantiamide-related dipeptide derivatives are formyl peptide receptor 1 antagonists 1-gen-2019 Mastromarino, Margherita; Kirpotina, Liliya N.; Schepetkin, Igor A.; Quinn, Mark T.; Lacivita, Enza; Leopoldo, Marcello
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 1-gen-2023 Rullo, Mariagrazia; La Spada, Gabriella; Miniero, Daniela Valeria; Gottinger, Andrea; Catto, Marco; Delre, Pietro; Mastromarino, Margherita; Latronico, Tiziana; Marchese, Sara; Mangiatordi, Giuseppe Felice; Binda, Claudia; Linusson, Anna; Liuzzi, Grazia Maria; Pisani, Leonardo
Design and Synthesis of Arylpiperazine Serotonergic/ Dopaminergic Ligands with Neuroprotective Properties 1-gen-2022 Mastromarino, M.; Niso, M.; Abate, C.; Proschak, E.; Dubiel, M.; Stark, H.; Castro, M.; Lacivita, E.; Leopoldo, M.
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders 1-gen-2022 Mastromarino, Margherita; Favia, Maria; Schepetkin, Igor A; Kirpotina, Lylia N; Trojan, Ewa; Niso, Mauro; Carrieri, Antonio; Leśkiewicz, Monika; Regulska, Magdalena; Darida, Massimiliano; Rossignolo, Francesco; Fontana, Stefano; Quinn, Mark T; Basta-Kaim, Agnieszka; Leopoldo, Marcello; Lacivita, Enza
G-protein coupled receptors involved in the resolution of inflammation: Ligands and therapeutic perspectives 1-gen-2020 Mastromarino, M.; Lacivita, E.; Colabufo, N. A.; Leopoldo, M.
Knowledge-Based Design of Long-Chain Arylpiperazine Derivatives Targeting Multiple Serotonin Receptors as Potential Candidates for Treatment of Autism Spectrum Disorder 1-gen-2021 Lacivita, E.; Niso, M.; Mastromarino, M.; Garcia Silva, A.; Resch, C.; Zeug, A.; Loza, M. I.; Castro, M.; Ponimaskin, E.; Leopoldo, M.
The N-Formyl Peptide Receptor 2 (FPR2) Agonist MR-39 Improves Ex Vivo and In Vivo Amyloid Beta (1–42)-Induced Neuroinflammation in Mouse Models of Alzheimer’s Disease 1-gen-2021 Trojan, E.; Tylek, K.; Schroder, N.; Kahl, I.; Brandenburg, L. -O.; Mastromarino, M.; Leopoldo, M.; Basta-Kaim, A.; Lacivita, E.